IM CannabisIMCC -10.70%36 Gross Margin % is 16.35% as of Mar. 2026, which is 10% below its 10-year median of 18.15. GuruFocus rates IMCC with a GF Score™ of 36/100 and a GF Value™ of $1.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 938 Drug Manufacturers companies, IM Cannabis ranks worse than 88.81% on this metric.
IM Cannabis Corp gross margin has been in long-term decline. The average rate of decline per year is -17.9%.
The historical rank and industry rank for IM Cannabis's Gross Margin % or its related term are showing as below:
IMCC'
s Gross Margin % Range Over the Past 10 Years
Min: 15.64 Med: 18.15 Max: 65.88
Current: 22.67
During the past 13 years, the highestGross Margin % of IM Cannabis was 65.88%. The lowest was 15.64%. And the median was 18.15%.
IMCC's Gross Margin % is ranked worse than 88.81% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs IMCC: 22.67
IM Cannabis had a gross margin of 16.35% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for IM Cannabis was -17.90% per year.
IM Cannabis (NAS:IMCC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
IM Cannabis had a gross margin of 16.35% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
IM Cannabis Gross Margin % Related Terms
IM Cannabis Gross Margin % Historical Data
* Premium members only.
The historical data trend for IM Cannabis's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMCC vs CPMD, SKYI, BSPK: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IM Cannabis Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Gross Margin % distribution charts can be found below:
* The bar in red indicates where IM Cannabis's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
IM Cannabis (IMCC) has a Gross Margin % of 16.35% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on IM Cannabis and its competitors. This is 10% below median its historical median of 18.15. Over the past decade, IM Cannabis' Gross Margin % has ranged from 15.64 to 65.88. According to the industry distribution chart, IM Cannabis ranks #833 out of 938 companies in the Drug Manufacturers industry, placing it in the top 88.8%.
Is IM Cannabis' Gross Margin % too high?
IM Cannabis' current Gross Margin % of 16.35% is 10% below median its 10-year median of 18.15. Over the past 10 years, this metric has ranged from a low of 15.64 to a high of 65.88. The Drug Manufacturers industry median Gross Margin % is 48.44. IM Cannabis' value of 16.35% is 66.2% below this industry median. Based on the distribution chart, IM Cannabis ranks #833 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IM Cannabis has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IM Cannabis' Gross Margin % compare to CPMD and SKYI?
According to the Drug Manufacturers industry distribution chart, IM Cannabis ranks #833 out of 938 companies for Gross Margin %. This places IM Cannabis in the lower half of its industry. The industry median Gross Margin % is 48.44. IM Cannabis' value of 16.35% is 66.2% below this benchmark. Historically, IM Cannabis' own Gross Margin % has ranged from 15.64 to 65.88 over the past decade. While the company's 10-year median is 18.15 vs. the industry median of 48.44, IM Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IM Cannabis's current Gross Margin % of 16.35% is 66.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on IM Cannabis and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IM Cannabis's current Gross Margin % is 16.35%, which is 10% below median its own 10-year median of 18.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IM Cannabis stock overvalued right now?
Based on GuruFocus' analysis, IM Cannabis (IMCC) is currently considered Possible Value Trap. The stock's GF Value™ is $1.39, compared to a current price of $0.14 — trading 89.8% below its estimated fair value. The current Gross Margin % is 16.35%, which is 10% below median its 10-year median of 18.15 and 66.2% below the Drug Manufacturers industry median of 48.44. IM Cannabis' overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For IM Cannabis (IMCC), the current Gross Margin % is 16.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IM Cannabis (IMCC) Overvalued in 2026?
Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued.
The current stock price of $0.14 is trading 89.8% below its estimated GF Value™ of $1.39.
GuruFocus considers IM Cannabis to be Possible Value Trap.
Key valuation signals for IMCC:
Gross Margin %: 16.35% (10% below median its 10-year median of 18.15)
GF Value™: $1.39 vs. price of $0.14 (89.8% below fair value)
Industry Position: 66.2% below the Drug Manufacturers median (#833 of 938)
No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score
Get the complete analysis for IMCC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMCC has been successfully added to your 
